Journal profile · PERIPHERAL VASCULAR DISEASE
Current Hypertension Reviews
ISSN 1573-4021 · eISSN 1875-6506 · Bentham
Current Hypertension Reviews: CAS Zone 4 · Medicine (2025 upgraded edition); subscription journal; median 112 days to acceptance (65 articles, last 24 months); 34 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Hypertension Reviews is published by Bentham and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Renin-Angiotensin System Studies and Cardiovascular Health and Disease Prevention, together about 48.5% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine27.6%
- Renin-Angiotensin System StudiesMedicine11%
- Cardiovascular Health and Disease PreventionMedicine9.9%
- Sodium Intake and HealthNursing5.5%
- Nitric Oxide and Endothelin EffectsMedicine5.3%
- Hormonal Regulation and HypertensionMedicine4.8%
- Chronic Kidney Disease and DiabetesMedicine4.5%
- Cardiovascular Function and Risk FactorsMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Internal Medicine | Q3 | 109/179 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2LetPub ·
- SJR 2026-06
- 0.29LetPub ·
- SNIP 2026-06
- 0.38LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 174OpenAlex ·
- 2-year mean citedness
- 1.37OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 4.84%LetPub ·
Volume
- Articles per year
- 25LetPub ·
Articles by year OpenAlex count · 728 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 0 | 414 |
| 2025 | 34 | 1 | 629 |
| 2024 | 20 | 4 | 769 |
| 2023 | 19 | 1 | 766 |
| 2022 | 16 | 2 | 742 |
| 2021 | 29 | 3 | 689 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
112 daysMedian, submission to acceptance · P25–P75 99 days – 135 days
- Acceptance to online
- median 181 days (65 articles)
- Submission to online
- median 294 days
- Sample
- 65 articles with submission and acceptance dates (78 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1573-4021
- Electronic ISSN
- 1875-6506
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Current Hypertension Reviews
What CAS zone is Current Hypertension Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Hypertension Reviews is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Current Hypertension Reviews?
Based on the dates recorded on 65 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 112 days (interquartile range 99–135 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Hypertension Reviews?
According to LetPub and DOAJ records, Current Hypertension Reviews is indexed in ESCI and Scopus.
Is Current Hypertension Reviews open access, and what is the APC?
Current Hypertension Reviews is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .